The establishment and development of the Izhevsk State Medical Academy is inseparably linked with the history of the Udmurt Republic and Russian Federation. The Izhevsk State Medical institute was founded in 1933, due to the urgent need of medical personnel in the developing Ural and Volga regions in Russia. Prominent medical researchers and scientists from different parts of Russia were invited to work in the institute (prof. V.N. Parin, prof. S.Y. Strelkov, prof. N.G. Stadnitsky, prof. B.A. Chentsov and others). They not only improved the quality of the teaching, but also created a solid foundation of scientific research. By the 90’s, the Izhevsk State Medical Institute had become a large teaching and scientific centre, not only in the Udmurt Republic, but in the Russian Federation. These improvements allowed the institution to achieved the status of Academy in 1995.

In the academy, fundamental and applied research, including scientific and highly-qualified specialist training are done in the areas of Physiology (prof. L.S. Isakova), Morphology (prof. V.M. Chuchkov, prof. G.V. Shumikhina), endocrinology (prof. V.V. Trusov), Family Medicine (prof. A.M. Korepanov, prof. Y.M. Vakhrushev), Cardiology (prof. prof. N.I. Maksimov), Paediatrics (prof. A.M. Ozhegov, prof. M.K. Ermakova), Surgery (prof. V.A. Sitnikov, prof. A.Y. Malchikov), Paediatric Surgery (prof. V.A. Bushmelev, prof. N.S. Strelkov), Forensics (prof. V.I. Viter), and Dentistry (prof. T.L. Redinova, prof. E.I. Deryabin). Not only are scientific questions studied, but also effective specialist training is done.

Along with traditional courses, additional scientific questions are studied: production of new pharmaceutical substances based on nanotechnologies (mechanoactivation of pharmaceutical substance), fundamental research in biological and medical mechanics and technology, with the aim of new designs solutions and developments in producing and upgrading biological and medical products, clinical-experimental research of immunomodulators of mechanisms of cardiovascular diseases in middle and old ages; culturing and adaptation of mesenchymal stem cells, and cellular vaccine production in order to correct traumatic injuries of central nervous system.